Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Finite Versus Continuous Nucleos(t)Ide Analogues Therapy in Patients With Chronic Hepatitis B: A Multicenter Randomized Controlled Trial

NCT05793268 is registered in ClinicalTrials.gov with E-DA Hospital as lead sponsor.

NCT NCT05793268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05793268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Finite Versus Continuous Nucleos(t)Ide Analogues Therapy in Patients With Chronic Hepatitis B: A Multicenter Randomized Controlled Trial
Lead sponsor
E-DA Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 20, 2022
Completion date
December 31, 2026
Enrollment
360 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b